Veoza (fezolinetant) – menopausal symptoms – pro
Veozah (fezolinetant) is a non-hormonal, prescription oral medication used to treat moderate to severe hot flashes and night sweats caused by menopause. Approved by the FDA in May 2023, it is the first neurokinin 3 (NK3) receptor antagonist for this purpose.
It is non-hormonal based interventions. As such, it is a good alternative and different from the formulary preferred drug. As an FDA approved option, it is appropriate to be used first.
CORTNEY CRESPO, MD, AND DEBORAH ERLICH,, Fezolinetant (Veozah) for the Treatment of Menopause Symptoms. Am Fam Physician. 2024;109(3):273-274
Fezolinetant (Veozah) for Menopausal Vasomotor Symptoms, The Medical Letter. June 26, 2023.
Veoazah Prescribing Information 2025